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ABSTRACT 
MicroRNAs (miRNAs) are important regulators of gene expression that bind 
complementary target mRNAs and repress their expression. Precursor miRNA 
molecules undergo nuclear and cytoplasmic processing events, carried out by the 
endoribonucleases, DROSHA and DICER, respectively, to produce mature 
miRNAs that are loaded onto the RISC (RNA-induced silencing complex) to 
exert their biological function. Regulation of mature miRNA levels is critical in 
development, differentiation and disease, as demonstrated by multiple levels of 
control during their biogenesis cascade. Here, we will focus on post-
transcriptional mechanisms and will discuss the impact of cis-acting sequences in 
precursor miRNAs, as well as trans-acting factors that bind to these precursors 
and influence their processing. In particular, we will highlight the role of general 
RNA-binding proteins (RBPs) as factors that control the processing of specific 
miRNAs, revealing a complex layer of regulation in miRNA production and 
function. 
 
 
Key Words: MicroRNAs (miRNAs); Terminal loop; Microprocessor; DGCR8; 
DROSHA; DICER; RNA-binding proteins (RBPs) 
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INTRODUCTION 
MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate the 
expression of a large proportion of cellular mRNAs. They have unique, diverse 
expression patterns (Landgraf et al. 2007) and affect many cellular processes and 
developmental pathways (Bartel 2018; Ebert and Sharp 2012). Most miRNA genes 
are transcribed by RNA polymerase II (Pol II), with the long primary transcript, 
termed pri-miRNA, harboring a hairpin structure, which comprises the miRNA 
sequence. Whereas many of these genes are transcribed as intronic clusters within 
protein-coding pre-mRNAs, others can be transcribed as independent gene units, or be 
encoded within long non-coding RNAs (Rodriguez et al. 2004; Kim and Kim 2007). 
 The biogenesis of miRNAs is carried out by two RNase III enzymes, DROSHA and 
DICER, which catalyze two subsequent processing events, in the nucleus and in the 
cytoplasm, respectively (Hutvágner et al. 2001; Ketting et al. 2001; Lee et al. 2003). 
The nuclear event is catalyzed by the Microprocessor complex, which comprises the 
RNase III type enzyme DROSHA, the double-stranded RNA-binding protein DGCR8 
(DiGeorge syndrome critical region 8 gene) and associated proteins (Denli et al. 2004; 
Gregory et al. 2004; Han et al. 2004; Landthaler et al. 2004). This nuclear processing 
event results in the production of  ~70 nucleotide (nt) stem-loop precursor miRNAs, 
termed pre-miRNAs (Han et al. 2004; Zeng et al. 2005), which are subsequently 
exported to the cytoplasm using the export receptor, Exportin-5 (Yi et al. 2003; 
Bohnsack et al. 2004; Lund et al. 2004). Once in the cytoplasm, pre-miRNAs undergo 
a final processing event, by another RNase type III enzyme, DICER, to give rise to 
miRNA duplexes (Hutvágner et al. 2001; Ketting et al. 2001). These are then 
incorporated into the RISC (RNA-Induced Silencing complex) together with an 
Argonaute (AGO) protein, where one strand is selected to become the mature miRNA 
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(Kobayashi and Tomari 2016). In addition, there are also non-canonical miRNA 
biogenesis pathways that lead to the production of functional miRNAs. These include 
mirtrons that are generated via pre-mRNA splicing and miRNAs generated from 
small nucleolar RNA (snoRNAs) precursors (for a review, see (Ha and Kim 2014)). 
Regulation of gene expression by miRNAs is also prevalent in plants; however 
several aspects of their biogenesis and function differ (for comprehensive reviews, see 
(Axtell et al. 2011; Naqvi et al. 2012; Bologna et al. 2013). Several excellent recent 
reviews have focused on the function of animal miRNAs (Bracken et al. 2016; Bartel 
2018; Gebert and MacRae 2018). Here, we will focus on post-transcriptional 
mechanisms that regulate miRNA production in animals, with a particular focus on 
the role of RNA-binding proteins (RBPs) in the post-transcriptional regulation of their 
biogenesis. 
 
Nuclear step of miRNA processing: The Microprocessor 
The nuclear phase of miRNA processing occurs co-transcriptionally acting on both 
independently transcribed and intron-encoded miRNA (Morlando et al. 2008). This 
co-transcriptional processing can be facilitated by HP1BP3, a histone H1-like 
chromatin protein, which interacts with both the Microprocessor and endogenous pri-
miRNAs to promote co-transcriptional miRNA biogenesis in human cells (Liu et al. 
2016). MiRNA precursors form RNA hairpins that need to be recognized by the 
Microprocessor. To distinguish primary miRNAs (pri-miRNAs) from other hairpin-
containing transcripts, additional identifiers are required. These determinants 
comprise a ~35bp stem harboring a mismatched GHG motif and also include three 
primary-sequence elements, a basal UG motif, an apical UGUG motif and a CNNC 
motif, which binds the SR protein, SRSF3, and is found downstream of approximately 
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60% of all pri-miRNA hairpins (Fig. 1A) (Auyeung et al. 2013; Fang and Bartel 
2015). Another proposed identifier of what constitutes a bona fide pri-miRNA stem-
loop is the presence of an N6-Methyladenosine(m(6)A) mark in the vicinity of the pri-
miRNA stem-loop. This mark is bound by a reader, the hnRNP protein, A2/B1, which 
interacts with DGCR8 and stimulates miRNA processing (Alarcón et al. 2015a, 
2015b; Knuckles et al. 2017). 
 The precise mechanism by which the Microprocessor recognizes pri-miRNAs and 
catalyzes their processing is beginning to be fully understood. In brief, the 
Microprocessor is a heterotrimeric complex, comprising one DROSHA and two 
DGCR8 molecules. The DGCR8 dimer interacts with the stem and apical elements of 
the pri-miRNAs through its double-stranded RNA-binding domains (dsRNA) and 
RNA-binding heme domain, respectively, leading to accurate and efficient processing. 
By contrast, DROSHA serves as a ruler to measure an 11 base pair (bp) distance from 
the basal single-stranded RNA-double stranded RNA (ssRNA-dsRNA) junction and 
cleaves the stem loop of primary miRNAs (Nguyen et al. 2015). Crucially, the 
orientation of this complex on the substrate is maintained by DROSHA and DGCR8 
recognizing the basal UG and apical UGUG motifs, respectively (Nguyen et al. 2015; 
Kwon et al. 2016). It has been recently shown that SRSF3, a member of the SR 
protein family of splicing factors promotes miRNA processing by recruiting 
DROSHA to the basal junction in a CNNC-dependent manner (Kim et al. 2018). The 
activity of the Microprocessor can be enhanced by the binding of heme, a ferric ion-
containing porphyrin, which promotes the interaction between the DGCR8 dimer and 
the apical UGUG motif, promoting Microprocessor activity (Quick-Cleveland et al. 
2014; Weitz et al. 2014; Partin et al. 2017; Nguyen et al. 2018).  
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Non- canonical functions of the Microprocessor 
Besides its established role in miRNA biogenesis, non-canonical functions for the 
Microprocessor have also been suggested (reviewed by (Macias et al. 2013; Pong and 
Gullerova 2018)). The first hint of more extended roles for the Microprocessor came 
from the observation that DROSHA cleaves pri-miRNA-like hairpins harbored within 
the 5’UTR of the mRNA encoding the DGCR8 protein itself, providing a feedback 
loop to control DGCR8 levels (Han et al. 2009; Kadener et al. 2009; Triboulet et al. 
2009). Furthermore, the phenotypic differences observed during early T cell 
development in the mouse, following Dgcr8/Drosha and Dicer inactivation, were 
correlated to transcriptomic changes that were unique to Drosha but not Dicer 
highlighting the existence of DROSHA-dependent, DICER-independent processing of 
RNAs (Chong et al. 2010). Thus, these non-canonical activities of the Microprocessor 
could affect cellular RNAs, beyond the described autoregulatory feedback that control 
levels of DGCR8 pre-mRNA. Identification of endogenous targets for DGCR8, 
revealed that the Microprocessor complex binds and regulates a large variety of 
cellular RNAs, other than miRNAs, including mRNAs, non-coding RNAs and 
transcripts derived from several human active retrotransposons (LINE-1, Alu) 
(Macias et al. 2012; Heras et al. 2013). Accumulating evidence suggests that these 
non-canonical activities of the Microprocessor do indeed have physiological 
relevance in the turnover of cellular RNAs. For instance, DROSHA has been show to 
negatively regulate the expression of the transcription factor Neurogenin by cleaving 
evolutionarily conserved hairpins present in the Neurogenin mRNA that are similar to 
pri-miRNAs (Knuckles et al. 2012). Furthermore, miRNA-independent functions of 
DGCR8 were also shown to be essential for neocortical development in the mouse. 
This was attributed to the action of the Microprocessor directly regulating the cortical 
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transcription factor, Tbr1, which also contains evolutionarily conserved hairpins that 
resemble miRNA precursors (Marinaro et al. 2017). Finally, DGCR8 can also 
associate with other nucleases, suggesting the existence of alternative DGCR8 
complexes that may regulate the fate of a subset of cellular RNAs, as shown by the 
DGCR8-mediated cleavage of small nucleolar RNAs (snoRNAs), which functions 
independently of DROSHA (Macias et al. 2015). 
 
Cytoplasmic step of miRNA processing: DICER 
In the canonical pathway, pre-miRNAs are exported to the cytoplasm and assembled 
into a complex containing DICER (Hutvágner et al. 2001) and the Hsp90 chaperone 
(Miyoshi et al. 2010). Subsequently, the pre-miRNA is cleaved by DICER, in tandem 
with TRBP (HIV-1 TAR RNA RNA-binding protein) and PACT (protein activator of 
PKR) (Fukunaga et al. 2012) (Fig. 1A). In this reaction DICER serves as a molecular 
ruler that measures the distance from the pre-miRNA basal end to the cleavage site 
adjacent to the terminal loop (TL) (also known as apical loop) (Macrae et al. 2006). 
This cleavage liberates the pre-miRNA TL element and creates an RNA duplex that 
interacts with the Argonaute 2 protein (AGO2). Of note, due to variable structural 
features of pre-miRNAs, the DICER-depended cleavage is often imprecise, 
generating two or more miRNA duplex variants that will give rise to distinct mature 
miRNAs (Starega-Roslan et al. 2015). The miRNA duplex is incorporated into an 
AGO2 protein to form the RNA-induced silencing complex (RISC), in an ATP-
dependent manner with the assistance of HSC70/HSP90 chaperones (Iwasaki et al. 
2010). Subsequently, AGO2 unwinds the RNA duplex and evicts the passenger strand 
forming the mature RISC complex (Kobayashi and Tomari 2016). The activated RISC 
then recognizes a specific mRNA sequence by complementary base-pairing resulting 
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in translation inhibition and/or RNA degradation (reviewed by (Fabian et al. 2010; 
Iwakawa and Tomari 2015). 
 
Role of RBPs in the regulation of miRNA biogenesis 
Due to the important role of miRNAs in the control of gene expression and organism 
development, the production of mature miRNAs is tightly regulated at multiple levels, 
including transcriptional and post-transcriptional steps. A variety of post-
transcriptional mechanisms, which affect DROSHA and DICER processing, as well 
as miRNA modification and turnover have been described (Krol et al. 2010; Siomi 
and Siomi 2010; Finnegan and Pasquinelli 2013; Creugny et al. 2018; Treiber et al. 
2018b). Dysregulation of miRNA production can result in global defects in gene 
expression and lead to human disease (Mendell and Olson 2012). As an example, 
impaired miRNA processing promotes cellular transformation and tumorigenesis 
(Kumar et al. 2007), and a global miRNA depletion is frequently observed in human 
cancers (Hata and Lieberman 2015; Lin and Gregory 2015).  
 Increasing evidence suggests that general RNA-binding proteins (RBPs), including 
splicing factors and other diverse RNA processing factors, act as post-transcriptional 
regulators of miRNA processing (for a review see (Ratnadiwakara et al. 2018)). In 
such scenario, the binding of an RBP to the terminal loop (TL) or a stem of a miRNA 
progenitor can positively or negatively affect the Microprocessor-mediated processing 
of pri-miRNA in the nucleus, and/or the DICER-mediated processing of a pre-miRNA 
in the cytoplasm (Fig. 1 B, C). Below, we will discuss the role of trans-acting factors 
that bind to precursor miRNAs and influence their nuclear and cytoplasmic 
processing by the Microprocessor and DICER, respectively. We will also focus on the 
contribution of sequence variation, exemplified by single nucleotide polymorphisms 
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(SNPs) present in the human genome that can have a role in the biogenesis of 
miRNAs. Finally, we will present attempts to target miRNA regulatory events using 
biological and synthetic compounds that could eventually lead towards the 
development of therapies that correct unbalanced miRNA production in disease. 
 
Role of LIN28 in the regulation of let-7 processing: Nuclear and cytoplasmic 
activities 
The first described example of an RBP regulating miRNA biogenesis at the post-
transcriptional level involved the role of the pluripotency promoting proteins LIN28A 
and LIN28B in the regulation of the let-7 family of miRNAs in pluripotent embryonic 
stem cells (ESCs). These proteins are enriched in undifferentiated cells and their 
expression is gradually switched off during differentiation. LIN28 proteins harbor two 
RNA-binding domains, a cold shock domain (CSD) and two Zinc knuckle domains 
that mediate recognition of the TL of let-7 in a sequence-specific manner. Binding of 
LIN28 proteins to let-7 precursors blocks their processing by different mechanisms at 
either the DROSHA and/or DICER level. Structural studies of LIN28 proteins in 
complex with sequences from several let-7 precursors revealed a bipartite recognition 
signal within the TL of let-7 precursors. The LIN28 CSD domain, which has a limited 
sequence specificity, binds to a let-7 closed loop to induce a conformational change of 
this precursor that facilitates binding of the CCHC zinc knuckles to a GGAG motif 
(Nam et al. 2011; Loughlin et al. 2012; Mayr et al. 2012). LIN28B binds to the TL of 
let-7 precursors and affects their processing by blocking the activity of the 
Microprocessor in the nucleus (Newman et al. 2008; Piskounova et al. 2008; 
Viswanathan et al. 2008). By contrast, LIN28A functions in the cytoplasm, where it 
recruits a TUTase (either TUT4 or TUT7) that adds a short oligo (U) stretch to the 
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3’end of precursor miRNAs and blocks their processing by DICER (Heo et al. 2009). 
The E3 ligase TRIM25 acts as an auxiliary factor for LIN28A by binding to the let-7a 
precursor and stimulating TUT-mediated uridylation (Choudhury et al. 2014). 
Subsequently, recruitment of the 3’ to 5’exoribonuclease DIS3L2 causes the 
degradation of the uridylated pre-let-7 (Chang et al. 2013; Ustianenko et al. 2013). 
This inhibitory effect of let-7 production is important to block miRNA-mediated 
differentiation in stem cells. LIN28A also inhibits the biogenesis of the neuro-specific 
miRNA-9 during neuronal differentiation of mouse cells (Nowak et al. 2014, 2017), 
albeit using an uridylation-independent mechanism. 
 
HnRNP A1 as a paradigm of an RBP regulating miRNA biogenesis in the 
nucleus 
Use of an unbiased in vivo cross-linking and immunoprecipitation protocol (CLIP) 
searching for RNA targets of the hnRNP protein, hnRNP A1, identified the miRNA 
precursor, pre-mir-18a (Guil and Cáceres 2007). This miRNA is expressed as part of 
the miR-17-92 cluster encoded as an intronic polycistron, that includes six individual 
miRNAs (miR-17, 18a, 19a, 20a, 19b-1 and 92a-1) and is frequently amplified and/or 
overexpressed in human cancers, being also termed oncomiR-1 (Concepcion et al. 
2012; He et al. 2005). Of interest, hnRNP A1 has been functionally characterized as a 
general RBP, with a role in many aspects of RNA processing, including alternative 
splicing regulation, IRES (internal ribosome entry site)-mediated translation and even 
telomere maintenance (Mayeda and Krainer 1992; LaBranche et al. 1998; Bonnal et 
al. 2005)(reviewed by (Jean-Philippe et al. 2013). HnRNP A1 has two RNA 
recognition motif (RRM) domains, each harboring conserved RNP-1 and RNP-2 
submotifs that represent the RNA-binding region and a C-terminal glycine-rich 
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domain (Mayeda et al. 1994). Mechanistically, we showed that hnRNP A1 binds to 
the TL of pri-mir-18a and induces a relaxation at the stem-loop structure near the 
DROSHA cleavage site, resulting in increased Microprocessor-mediated processing 
(Michlewski et al. 2008) (Fig. 2 A,B). The processing of the other miRNAs in this 
cluster is not affected, indicating that hnRNP A1 acts locally to influence the 
processing of its target pri-miRNA. Importantly, we also observed phylogenetic 
sequence conservation of TL sequences of precursor miRNAs, suggesting that these 
sequences act as a landing pad for regulatory factors that could have a positive or 
negative role in miRNA production, either at the level of DROSHA and/or DICER 
(Michlewski et al. 2008, 2010). More recently, using an integrative structural biology 
approach combined with biochemical and functional assays, we were able to 
demonstrate that hnRNP A1 forms a 1:1 complex with pri-mir-18a, in which the 
tandem RRM domains of hnRNP A1 recognize two UAG motifs in the pri-mir-18a 
TL and the proximal stem region (Fig. 2B). This structural approach also confirmed 
that binding of hnRNP A1 to the TL induces an allosteric destabilization of base-
pairing in the pri-mir-18a stem that promotes its processing (Kooshapur et al. 2018). 
Of interest, binding of hnRNP A1 to the conserved terminal loop of a precursor 
miRNA does not always result in enhanced miRNA processing. We showed that 
hnRNP A1 binding to the TL of pri-let-7 has an inhibitory role in let-7 production in 
differentiated cells. This is due to a different mechanism from that shown for pri-mir-
18a, and involves antagonistic roles for hnRNP A1 and other hnRNP protein, the KH-
type splicing regulatory protein, KSRP, which was shown to promote let-7 biogenesis 
in differentiated cells (Trabucchi et al. 2009; Michlewski and Cáceres 2010) (Fig. 
2C). Interestingly, KSRP not only regulates the processing of let-7, but also binds to 
the TL of a subset of pri- and pre-miRNAs that includes miR-20, miR-26b, miR-106a, 
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miR-21, miR-16, and promotes both DROSHA and DICER-mediated steps (Table 
1)(Trabucchi et al. 2009, 2010). Thus, these findings with LIN28 and hnRNP A1 
suggested a previously uncharacterized role for general RBPs as auxiliary factors that 
influence the processing of specific miRNAs and prompted the search for novel 
regulators. 
 
The terminal loop of precursor miRNAs as a hub for regulation of DROSHA and 
DICER activities 
A flexible and long TL of approximately 10 nucleotides (nt) was proposed to be 
required for efficient DROSHA processing (Zhang and Zeng 2010); however specific 
sequences at the TL region of some pri- and pre-miRNAs were shown to only have a 
minor effect on miRNA production (Zeng and Cullen 2003; Han et al. 2006). In 
agreement, most precursor miRNAs display a poor phylogenetic conservation in the 
TL region, when compared with the high level of conservation observed in mature 
miRNA sequences (Berezikov et al. 2005; Akhtar et al. 2016). However, a 
phylogenetic analysis of human pri-miRNAs sequences revealed that approximately 
~14% (74 out of 533) of all miRNAs displayed high conservation of the TL sequence 
(Michlewski et al. 2008), indicating that these sequences could act as a landing 
platform for the binding of auxiliary factors, such as hnRNP A1, that influence the 
post-transcriptional regulation of miRNA production. This was further validated by 
the use of of 2’O-methyl oligonucleotides complementary to conserved terminal 
loops, which we termed LooptomiRs (for Loop Targeting Oligonucleotide anti 
miRNAs) that block the in vitro processing of precursor miRNAs (Michlewski et al. 
2008). We attributed this to a block exerted by looptomiRs on conserved sequences 
within the TL that are recognized by auxiliary factors required for the efficient 
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processing of these targeted miRNAs in vitro. Conversely, it is also likely that 
looptomiRs could block the access of factors that negatively regulate processing of 
target precursor miRNAs.   
 In several cancers, the tumor suppressive role of let-7 is abrogated by the increased 
expression of its negative regulator, LIN28. Building on this concept, short, loop-
targeting oligoribonucleotides were used to block binding of the negative regulator 
LIN28 to the precursor of let-7. These looptomiRs selectively antagonized the 
docking of LIN28, but still allowed the processing of pre-let-7a-2 by DICER, leading 
to suppression of growth in cancer cells (Roos et al. 2014). An RNA aptamer that 
specifically targets the pri-mir-17-92 cluster was identified through an in vitro 
selection process. This aptamer binds to the TL of pri-mir-18a and inhibits the 
biogenesis not only of miR-18a, but also of all other five miRNAs within this cluster 
(Lünse et al. 2010). By contrast, looptomiR targeting miR-18a only affects the 
processing of this miRNA, reflecting mechanistic differences on how these two 
reagents influence miRNA biogenesis (Michlewski et al. 2008; Lünse et al. 2010). 
These evidences strongly suggest that TL recognition by RBPs could constitute a 
general mechanism to regulate miRNA biogenesis, that operates via different 
mechanisms, such as altering the RNA structure of the precursor itself, recruiting 
additional RNA enzymes and/or affecting the recruitment and/or activity of core 
processing complexes associated with the Microprocessor and/or DICER. Indeed, a 
growing number of canonical and newly characterised RBPs have been shown to bind 
to TLs and regulate miRNA biogenesis (Choudhury and Michlewski 2012; Castilla-
Llorente et al. 2013) (Fig. 1B,C and Table 1).  
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Genetic variation 
An increasing number of SNPs and rare mutations within precursor and/or mature 
miRNA sequences linked to human disease have been reported (Hogg and Harries 
2014; Króliczewski et al. 2018). Despite correlations between the presence of 
polymorphisms in pri-and pre-miRNAs and the corresponding levels of mature 
miRNAs, the mechanism by which sequence variation and RNA structure control 
miRNA biogenesis remains mostly enigmatic. A rare genetic variation in the TL of 
pri-miR-30c-1 (G27 to A) that was found in breast and gastric cancer patients results in 
increased levels of mature miR-30c (Shen et al. 2009; Fernandez et al. 2017). This 
genetic variant directly affects the Microprocessor-mediated processing of pri-mir-
30c-1 by inducing a secondary RNA structure rearrangement that opens up the pri-
miRNA stem and facilitates binding of the trans-acting factor SRSF3 (Fernandez et al. 
2017), a factor which was described to promote Microprocessor activity on a subset of 
miRNAs (Auyeung et al. 2013) (Fig. 3). This finding raises the interesting hypothesis 
that primary sequence determinants in conjunction with RNA structure can act as 
regulators of miRNA biogenesis. Although this constitutes a largely unexplored area, 
the emerging picture is that human genetic variation could indeed not only affect 
miRNA function by targeting either miRNA binding sites in the 3’UTRs of target 
genes and/or miRNA seed sequences, but it could also have an essential role in the 
modulation of miRNA biogenesis (Hogg and Harries 2014). The role of pri-miRNA 
secondary structure is also sensitive to DROSHA levels, since it has been 
demonstrated that the Microprocessor processes miRNAs without mismatches more 
efficiently than mismatched miRNAs. Thus, changes in DROSHA expression, if 
limiting, could introduce another avenue to regulate miRNA production (Sperber et 
al. 2014). Another systematic study identified additional structural elements and 
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sequence distribution for optimal DROSHA processing (Roden et al. 2017). This 
study also predicts that a small but significant fraction of human SNPs could alter pri-
miRNA processing, which ultimately could influence the levels of mature miRNA 
and their biological function. These findings highlight the interplay between genetics, 
RNA structure and post-transcriptional regulation of miRNA biogenesis. 
 
Auxiliary factors in post-transcriptional control of miRNA biogenesis 
In addition to LIN28 proteins and hnRNP A1, several other RBPs recognize the TL of 
miRNA precursors and influence, either positively or negatively, their processing 
(Fig. 1B, C and Table 1). In the following section, we will illustrate the role of a 
number of RBPs in the regulation of miRNA production.  
 
TPD-43 
The hnRNP protein, TDP-43 (TAR DNA-binding protein-43) also promotes the 
processing of a subset of precursor miRNAs acting at both the level of DROSHA and 
DICER processing and this activity is required for neuronal outgrowth (Kawahara and 
Mieda-Sato 2012; Di Carlo et al. 2013). It was shown that TDP-43 is indeed a 
component of the Microprocessor complex (Gregory et al. 2004) and  its 
Microprocessor-related role affects the biogenesis of a subset of at least six miRNAs, 
including miR-558-3p, miR-574-3p, and both strands of miR-132 and miR-143 
(Kawahara and Mieda-Sato 2012). In contrast, cytoplasmic TDP-43 was shown to 
bind to the TL of pre-miRNAs and interact with the DICER complex (Kawahara and 
Mieda-Sato 2012). 
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SRSF1  
The splicing factor SRSF1 (also known as SF2/ASF), which is the prototype of the 
SR family of splicing regulators, can also promote the maturation of a subset of 
miRNAs, including miR-7, miR-29b, miR-221 and miR-222. In the case of pri-mir-7, 
this was shown to be independent of splicing and involved SRSF1 binding to a 
consensus motif in the stem-loop of pri-mir-7 leading to an increase in DROSHA 
activity, yet the exact mechanism by which this occurs remains enigmatic (Wu et al. 
2010). 
 
FUS and EWS 
Two members of the TET family of proteins, FUS (also known as TLS, translocated 
in Liposarcoma) and Ewing's sarcoma (EWS) have been shown to affect miRNA 
biogenesis. FUS/TLS, which is associated with familial forms of Amyotrophic Lateral 
Sclerosis (ALS), promotes the biogenesis of a subset of miRNAs in neuronal cells. It 
is recruited to chromatin, associates with DROSHA and facilitates the recruitment of 
the Microprocessor complex to substrate pri-miRNAs, promoting the biogenesis of 
neuronal miR-9, miR-125b and miR-132 (Morlando et al. 2012). Interestingly, 
mutations in both TDP-43 and FUS have been linked with the aetiology of ALS, 
suggesting a possible link between mutations in these miRNA regulators and altered 
miRNA biogenesis in ALS (Goodall et al. 2013; Paez-Colasante et al. 2015). 
 The Ewing Sarcoma protein (EWS) has a dual and opposing role in miRNA 
production. On one hand, EWS has been shown to downregulate DROSHA at the 
transcriptional level (Kim et al. 2014b), but it also has a positive role in miRNA 
production by binding to flanking sequences in the stem-loop region of pri-miRNAs 
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and promoting the cotranscriptional recruitment of the Microprocessor to chromatin 
(Ouyang et al. 2017).  
 
RBFOX proteins  
RBFOX3 binds to a subset of pri-miRNAs and directly regulates the Microprocessor-
mediated processing of selected pri-miRNAs in neuronally differentiated P19 cells 
and mouse brain, with stimulatory or blocking effects, depending on the miRNA (Kim 
et al. 2014a). Binding of RBFOX3 to the TL or to the stem of individual pri-miRNAs 
results in recruitment or exclusion of the Microprocessor differentially affecting the 
processing of the respective pri-miRNAs. Surprisingly, this role in miRNA biogenesis 
was independent of the cognate binding site for RBFOX3, the UGCAUG motif (Kim 
et al. 2014a). In contrast, a more recent study also found a role for RBFOX proteins, 
in the regulation of miRNA biogenesis, but in this case involved sequence-specific 
binding of the conserved RBFOX2 RRM to pri-mir-20b and pri-mir-107 containing 
the cognate motif in their terminal loops. This binding alters the conformation of these 
precursors leading to inhibition of DROSHA processing (Chen et al. 2016). 
 
HuR and MSI2 
Several miRNAs are expressed in a tissue- or cell type-specific manner, thereby 
contributing to tissue and cell identity and function (Landgraf et al. 2007). An 
example of an RBP determining the tissue-specific expression of a target miRNA is 
illustrated in the case of the brain-enriched expression of miR-7, which is processed 
from the ubiquitous hnRNP K pre-mRNA transcript. This brain-specificity is 
achieved by the inhibition of pri-mir-7 processing in non-neural cells by the combined 
action of two RBPs, Musashi RNA-binding protein 2 (MSI2) and the Hu antigen R 
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(HuR), which bind to the TL of pri-mir-7 (Choudhury et al. 2013). Mechanistically, 
HuR binds to the TL of pri-mir-7 and recruits MSI2. Both proteins act then 
synergistically to stabilize the pri-mir-7 stem-loop structure and inhibit 
Microprocessor cleavage. This is in agreement with a study showing that HuR 
depletion results in a significant increase of miR-7 without a noticeable change in the 
pri-mir-7 levels (Lebedeva et al. 2011). Notably, mature miR-7 is sequestered by a 
circular RNA, ciRS-7, which is primarily expressed in the cerebellum, indicating a 
sophisticated mechanism of miR-7 regulation (Hansen et al. 2013; Memczak et al. 
2013). Other miRNAs, such as miR-505, miR-92a-1, or miR-224 are also sensitive to 
MSI2 and HuR depletion but the precise mechanism of action awaits further 
characterization (Choudhury et al. 2013). The biogenesis of miR-675 is inhibited by 
HuR in intestinal tissue by blocking processing of long non-coding RNA H19 (Zou et 
al. 2016). Moreover, maturation of miR-199a is blocked by HuR in hepatocellular 
carcinoma in hypoxic conditions that promote glycolytic metabolism and cancer 
proliferation (Zhang et al. 2015). Finally, HuR inhibits processing of miR-133b from 
linc-MD1 non-coding RNA contributing to early stages of the muscle differentiation 
programme (Legnini et al. 2014). It is yet to be established whether HuR controls 
these processes alone or in a complex with MSI2.  
 
ADARs  
RNA editing and RNA editing enzymes can also act to regulate miRNA biogenesis. 
Adenosine deaminases acting on RNA (ADARs) are responsible for the editing of 
adenosine residues to inosine in double-stranded RNA (dsRNA). They also affect 
RNA interference (RNAi) and miRNA processing by deamination of specific 
adenosines to inosine. RNA editing of pri-mir-142, which is expressed in 
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hematopoietic tissues, blocks its DROSHA-mediated processing. The resulting edited 
pri-miR-142 is subsequently degraded by Tudor-SN, a component of RISC and also a 
ribonuclease specific to inosine-containing dsRNAs (Yang et al. 2006). In contrast, 
RNA editing of pri-mir-151 blocks it processing by DICER in the cytoplasm 
(Kawahara et al. 2007). It was also demonstrated that ADAR proteins can influence 
miRNA biogenesis independently of their enzymatic activity, as evidenced by the role 
of ADAR2 in blocking the Drosha-mediated processing of miR-376a-2, 
independently of its catalytic RNA editing activity (Heale et al. 2009).   
 
NF45/NF-90  
The heterodimer NF45-NF90 is an RNA-binding protein complex that regulates the 
post-transcriptional expression of a large number of cellular RNAs. It also has a 
negative role in the processing of pri-mir-7 in hepatocellular carcinoma (HCC). The 
expression of this heterodimer is elevated in primary HCC tissues compared with 
adjacent non-tumor tissues. The NF90-NF45 heterodimer binds to pri-mir-7-1 and 
blocks its processing. The biological effect of this repression is the elevation of EGF 
receptor levels that results in the promotion of cell proliferation in HCC (Higuchi et 
al. 2016). 
 
YB-1 
The Y box-binding protein (YB-1), a member of DNA/RNA binding family of 
proteins with an evolutionarily conserved cold shock domain (CSD), is a modulator of 
miRNA processing in glioblastoma multiforme (GBM). A CLIP approach revealed 
that YB-1 binds to the TL of pri-/pre-mir-29b-2 and regulates its processing by 
blocking the recruitment of the Microprocessor and DICER to its precursors. 
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Downregulation of miR-29b by YB-1, which is up-regulated in GBM, is crucial for 
cell proliferation (Wu et al. 2015). 
 
MBNL1 
MBNL1 stimulates the production of miR-1 by binding to a UGC motif located 
within the TL of pre-miR-1 and competing for the binding of the negative regulator 
LIN28A in the cytoplasm. In Myotonic dystrophy, which is an RNA gain-of-function 
disease caused by expansions of CUG or CCUG repeats, MBNL1 is sequestered by 
these expansions. This results in a decreased miR-1 processing in heart samples from 
patients with myotonic dystrophy (Rau et al. 2011), contributing to pathophysiology. 
 
BCDIN3D 
The RNA-methyltransferase, BCDIN3D, regulates miRNA biogenesis by methylating 
the 5' monophosphate end of precursor miRNAs, thus blocking the recognition of 
5’monophosphate by Dicer and inhibiting miRNA processing. In particular, it was 
shown that BCDIN3D phospho-dimethylates pre-mir-145 both in vitro and in vivo 
leading to a reduced processing by Dicer in vitro (Xhemalce et al. 2012). 
 
Signaling and miRNA biogenesis 
Post-translational modifications of miRNA processing factors have been identified, 
including phosphorylation as well as ubiquitination and sumoylation that can affect 
DGCR8, DROSHA and/or DICER complex components (reviewed by (Ha and Kim 
2014)). It has been shown that miRNA biogenesis can also be regulated in a cell-
density-dependent manner (Hwang et al. 2009), and this is mediated by the tumor-
suppressive Hippo pathway. At low cell density, when the Hippo signaling is 
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suppressed, its component YAP re-localizes to the nucleus where it binds and 
sequesters a Microprocessor-associated component, the RNA helicase DDX17 (also 
known as p72), thus, down-regulating Microprocessor activity. In contrast, at high 
cell density the Hippo-induced cytoplasmic retention of YAP restores the association 
of DDX17/p72 with the Microprocessor stimulating its activity. Thus, the frequent 
inactivation the Hippo pathway or expression of constitutively active YAP observed 
in many cancers results in a widespread miRNA suppression in cells and tumors, 
which explains the global downregulation of miRNAs during cancer (Harvey et al. 
2013; Mori et al. 2014). 
 
SMADs 
In particular, the Microprocessor-mediated step of miRNA biogenesis can be 
regulated by multiple signaling pathways, such as the Transforming Growth Factor 
beta (TGF-β) and bone morphogenetic protein (BMP) pathways. Mechanistically, 
TGF-β and BMP-specific SMAD signal transducers are recruited to pri-mir-21 in a 
complex with the RNA helicase p68 and facilitate its DROSHA-mediated processing 
(Davis et al. 2008, 2010). The induction of miR-21 promotes the contractile 
phenotype in human vascular smooth muscle cells (VSMCs); thus, regulation of 
miRNA biogenesis by ligand-specific SMAD proteins acts to control the vascular 
smooth muscle cell phenotype. 
 
Tumor suppressors, p53 and BRCA1  
As noted above, a global downregulation of miRNAs is commonly observed in 
human cancers (Lin and Gregory 2015). The tumour suppressor, p53, has been shown 
to act as an enhancer of miRNA biogenesis in response to DNA damage, promoting 
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the post-transcriptional maturation of a subset of miRNAs with growth-suppressive 
function, which includes miR-16-1, miR-143 and miR-145. Mechanistically, p53 
interacts with the Microprocessor complex by binding to the DEAD-box RNA 
helicase p68 (also known as DDX5) in HCT116 cells and human diploid fibroblasts 
and promotes the processing of pri-miRNAs (Suzuki et al. 2009). The tumor 
suppressor breast cancer 1 protein (BRCA1) has also been shown to promote the 
processing of a subset of pri-miRNAs, which include let-7a-1, miR-16-1, miR-145, 
and miR-34a. BRCA1 interacts with components of the Microprocessor complex, 
namely DROSHA and the RNA helicase DDX5, as well as with SMAD3, p53 and the 
DHX9 RNA helicase. This novel function of BRCA1 in miRNA biogenesis could be 
linked to its well-established roles in tumor suppression and maintenance of genomic 
stability (Kawai and Amano 2012).  
 
Genome-wide identification of RBPs that regulate miRNA production 
The initial findings that RBPs bind to terminal loop regions of miRNAs and influence 
their processing, such as the examples described above (Table 1), prompted a global 
search for additional factors that control miRNA processing. Several strategies have 
been developed with the aim of identifying precursor miRNAs (both pri- and pre-
mRNAs) whose biogenesis is affected by the binding of RBPs. These include the 
identification of additional miRNA precursors bound by cognate RBPs (Towbin et al. 
2013), and identification of novel RBPs for a particular precursor miRNA sequence/s 
(Choudhury and Michlewski 2018; Treiber et al. 2017, 2018a). A biochemical method 
involving an RNA pull-down combined with SILAC mass spectrometry (RP-SMS) 
led to the identification of trans-acting factors that regulate the processing of miR-7, 
miR-9 and let-7 (Choudhury and Michlewski 2018). In the case of miR-9, which is 
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specifically expressed in the brain, this approach led to the identification of LIN28A, 
which binds to pri-mir-9 in differentiating cells and induces the degradation of its 
precursor through a uridylation-independent mechanism (Nowak et al. 2014). 
 A recent proteomics-based pull-down approach focused on the identification of 
RBPs that recognize 72 different pre-miRNA hairpins used as baits in 11 different cell 
lines. This identified approximately 180 RBPs that interact specifically with this 
subset of precursor miRNAs, including known RBPs, splicing factors, as well as other 
mRNA processing factors (Treiber et al. 2017, 2018a). Interestingly, this approach 
revealed that both terminal loops, but also stem regions of miRNA precursors, could 
be specifically recognized by regulatory RBPs. In several cases, loss-of-function 
experiments validated the impact of these RBPs in the regulation of mRNA 
biogenesis, although their mechanism of action remains enigmatic. A recent study 
relied on a high-throughput computational screen to assess a role for 126 RBPs in 
miRNA biogenesis, using available eCLIP datasets from ENCODE. Those RBPs with 
enriched binding in the vicinity or within miR-encoding genomic loci represent 
candidate trans-acting factors for miRNA processing. This exercise resulted in the 
identification of 116 putative regulators that bind at 1,871 annotated human precursor 
miRNA loci. These candidate RBPs have a potential a role either positive or negative 
at different steps of the miRNA biogenesis cascade. Of interest, some of the 
interactions of individual RBPs with subsets of precursor miRNAs seem to be cell-
type specific. Importantly, this difference was noted even when the corresponding pri-
miRNA is expressed in both cell lines. The authors further showed that most RBPs 
bind fewer than 25 unique miRNA loci and in most cases, depletion of individual 
RBPs affects the corresponding mature miRNA levels (Nussbacher and Yeo 2018). 
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The precise mechanisms of post-transcriptional regulation that these proteins use to 
control of miRNA biogenesis are currently unknown. 
 
Role of long non-coding RNAs in the control of miRNA biogenesis 
A role for long non-coding RNAs (lncRNAs) in the post-transcriptional regulation of 
miRNA processing has also been recently described (Table 2). Uc.283+A, a lncRNA 
transcribed from an ultraconserved region, inhibits the Drosha-mediated processing of 
pri-mir-195. This regulatory event requires complementarity between the lower 
stem region of the pri-mir-195 transcript and an ultraconserved sequence in 
Uc.283+A. The proposed mechanism involves lower-stem strand invasion by 
Uc.283+A, which impairs Microprocessor recognition and blocks pri-
miRNA processing (Liz et al. 2014). RNA 4 (RNCR4), a retina-
specific long noncoding RNA, stimulates the timed processing of the pri-mir-183-92-
182 cluster, which is repressed at an earlier developmental stage by the RNA helicase 
Ddx3x, during mouse retina development (Krol et al. 2015). Finally, the heterodimer 
of splicing factors, NONO/PSF, which are components of the paraspeckles, bind a 
large number of pri-miRNAs and promote the Microprocessor-mediated processing of 
these precursors in HeLa cells. The lncRNA, NEAT1, interacts with NONO/PSF and 
scaffolds RBPs and the Microprocessor to globally promote miRNA processing (Jiang 
et al. 2017). 
 
Physiological relevance of miRNA regulation and Human disease 
Given the central role that miRNAs have in controlling the expression of target 
mRNAs, it is unsurprising that dysregulation of miRNA production leads to aberrant 
gene expression due to the misregulated expression of target mRNAs. This can affect 
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cellular homeostasis, as well as many developmental pathways and have an impact on 
the development of human disease. One of the most studied examples is the altered 
expression of a variety of miRNAs in many different types of cancer, which arises as 
a consequence of mis-regulation of miRNA production, but also through the presence 
of mutations in miRNA processing components (reviewed by (Lekka and Hall 2018)). 
Mutations in Microprocessor components, DROSHA and DGCR8 have been 
identified in Wilms tumors, a pediatric kidney tumor (Rakheja et al. 2014; Walz et al. 
2015; Wegert et al. 2015). Conversely, DICER mutations have also been linked to 
several human conditions, including early childhood tumors (Heravi-Moussavi et al. 
2012; Wu et al. 2013) (reviewed by (Foulkes et al. 2014; Hata and Kashima 2016).  
 The regulation of let-7 miRNA precursors by the LIN28 proteins is a clear example 
of how alterations to post-transcriptional regulation of miRNA precursors can indeed 
lead to cancer (Viswanathan et al. 2008, 2009; Lightfoot et al. 2011). In the section 
below, we will discuss novel approaches used in an attempt to influence miRNA 
biogenesis by targeting regulatory RBPs that regulate the production of miRNAs. 
 
Synthetic and natural inhibitors of miRNA biogenesis 
Several strategies have been developed to affect the production of miRNAs, targeting 
their nuclear and cytoplasmic processing machineries and/or factors that regulate their 
biogenesis. We have described above the use of looptomiRs and Aptamers to target 
the recognition of terminal loops by RBPs and regulate miRNA processing. Several 
alternative approaches aimed to identify small molecules that bind to miRNA 
precursors or to RBPs that regulate miRNA biogenesis. These include the 
identification of a peptoid ligand that interacts with the apical loop of pri-mir-21 and 
inhibits cleavage by DROSHA (Diaz et al. 2014), of a benzimidazole that inhibits the 
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biogenesis of miR-96 (Velagapudi et al. 2014) and of polyamine derivatives that 
block the DICER-mediated processing of pre-mir-372 processing (Staedel et al. 
2018). A different strategy was developed to inhibit miRNAs that are overexpressed 
in human cancers, such as miR-21, in which a cyclic β-hairpin peptidomimetic binds 
to RNA stem-loop structures of miRNA precursors, with potent affinity and 
specificity. This peptide was shown to recognize the DICER cleavage site and inhibit 
miR-21 processing (Shortridge et al. 2017). Another study focusing on miR-21, used 
small molecule screening and 3D structure modeling and identified AC1MMYR2 
(2,4-diamino-1, 3-diazinane-5-carbonitrile) as a potent inhibitor of pre-mir-21 
cleavage by DICER (Shi et al. 2013). This inhibitor reversed epithelial-to-
mesenchymal transition and suppressed tumor growth. Oleic acid (a natural 
monounsaturated fatty acid produced by plants and animal cells) inhibits the RNA-
binding activity of Musashi RNA binding protein 2 (MSI2), a negative regulator of 
pri-mir-7 processing, by binding to its N-terminal RRM (Clingman et al. 2014; 
Choudhury et al. 2013). Thus, the action of oleic acid could be used to disrupt the 
formation of a negative regulatory complex and lead to stimulation of miR-7 
biogenesis (Kumar et al. 2017). Such strategies could reduce the levels of a miR-7 
target genes such as the EGFR oncogene, to potentially alleviate its deleterious effects 
in high-grade glioblastomas, where miR-7 is post-transcriptionally downregulated 
(Kefas et al. 2008). Recent small-molecule screening have identified compounds that 
inhibit Lin28 binding to RNA (Roos et al. 2016; Wang et al. 2018). One such 
compound, LI17, potently inhibited Lin28-mediated oligouridylation of pre-let-7 in 
vitro and in cells, causing a concomitant increase in mature let-7 levels (Wang et al. 
2018). Likewise, another compound de-repressed let-7 and inhibited proliferation and 
stem-like properties in human cancer cells (Roos et al. 2016). These examples 
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demonstrate that selective pharmacologic inhibition of RBPs involved in post-
transcriptional regulation of miRNA biogenesis could provide a foundation for 
therapeutic intervention in diseases underpinned by deregulated miRNA levels. 
 
Conclusion and Perspectives 
Several layers of tightly controlled regulation have evolved to maintain the levels of 
mature miRNAs to fine-tune gene expression during development, differentiation and 
specific cellular functions. Such multi-faceted regulation ultimately prevents gross 
changes in gene expression that can contribute to numerous diseases. Among these 
mechanisms of control, post-transcriptional steps are predominant, and increasing 
evidence shows the central role of general RBPs in the control of miRNA production. 
The binding of RBPs to terminal loop (TL) sequences within miRNA precursors (pri- 
and pre-miRNAs) has emerged as a general mechanism to regulate the activity of 
DROSHA and/or DICER. This can encompass different mechanisms, such as 
conformational changes and dynamic destabilization induced by the binding of these 
auxiliary factors. For example, the binding of hnRNP A1 or Rbfox proteins to pri-
miRNAs leads to structural changes that affect Microprocessor binding and/or activity 
(Kooshapur et al. 2018; Chen et al. 2016) (Table 1). Another common mechanism is 
antagonistic binding of the regulatory RBP to either a positive or negative regulator, 
as seen with the competitive binding of hnRNP A1 and KSRP to let-7 precursors in 
differentiated cells (Michlewski and Cáceres 2010), or MBNL-1 antagonizing LIN28 
binding to pri-mir-1 (Rau et al. 2011). Thus, increased knowledge of binding sites and 
regulatory mechanisms could facilitate the manipulation of individual miRNA 
expression. Similarly, recent efforts have relied on the use of oligonucleotide 
approaches and/or chemical or biological compounds to target the LIN28/let-7 
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interaction. In principle, these approaches could be expanded to compete out the 
binding of positive or negative regulators to individual precursor miRNAs and modify 
the outcome of the biogenesis pathway to correct the unbalanced miRNA levels.  
 Extensive genetic variation leading to altered miRNA biogenesis represents another 
largely unexplored mechanism of regulation. We and others have established that 
primary sequence determinants and RNA structure are important regulators of 
miRNA biogenesis. Of interest, polymorphisms and mutations within or proximal to 
miRNAs are frequently overlooked in disease and trait studies searching for 
functionally important variants, but could have an important role in determining levels 
of miRNA expression. In the near future, efforts will focus on the identification and 
functional characterization of additional RBPs or other regulators that affect miRNA 
biogenesis, as illustrated by recent genome-wide efforts (Treiber et al. 2017; 
Nussbacher and Yeo 2018). Our expanding knowledge about the mechanisms that 
regulate miRNA production will be essential to understand and treat human diseases 
that arise from deregulated gene expression.  
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FIGURE LEGENDS 
FIGURE 1. (A) The canonical pathway of miRNA biogenesis, including the 
Microprocessor-mediated (DROSHA/DGCR8) step in the nucleus followed by 
DICER processing in the cytoplasm. Structural and sequence features important for 
miRNA processing are highlighted in both the pri-mir and pre-miR molecules. (B) 
Positive regulators of miRNA biogenesis bind to the terminal loop (TL) or other 
elements within miRNA precursors (pri-mir and pre-mir) and stimulate Drosha and/or 
Dicer processing, leading to increased levels of mature miRNAs (miR). The terminal 
loop (TL), also known as apical loop, is depicted in red. (C) Negative regulators of 
miRNA biogenesis bind to TL or other elements within miRNA precursors (pri-mir 
and pre-mir) and abrogate Drosha and/or Dicer processing, leading to decreased levels 
of mature miRNAs (miRs). The terminal loop (TL), also known as apical loop, is 
depicted in red. 
 
FIGURE 2. HnRNP A1 as a paradigm for RBP-mediated regulation of miRNA 
biogenesis in the nucleus. (A) Binding of hnRNP A1 to the TL of pri-mir-18a induces 
a structural rearrangement that results in enhanced Drosha processing. (B) Each RRM 
of hnRNP A1 recognizes an UAG motif in the TL of pri-mir-18a. (C) Binding of 
hnRNP A1 to the TL of pri-let-7 in differentiated cells outcompetes binding of the 
stimulatory factor, KSRP, resulting in decreased Drosha processing. 
 
FIGURE 3. Influence of genetic variation on miRNA biogenesis. (A) Schematic 
structure of pri-mir-30c-1 with the CNNC motif (CAUC) occluded by the RNA 
secondary structure in the G27 (wild-type) variant (indicated by a G in the TL). (B) A 
single G to A substitution (A27) present in the terminal loop of pri-mir-30c-1 in breast 
     Michlewski and Caceres 
 30 
and gastric cancer patients leads to a secondary RNA structure rearrangement that 
facilitates binding of SRSF3 to the CAUC sequence determinant, causing increased 
Microprocessor-mediated processing and elevated miR-30c levels.  
 
TABLE 1. RBPs that regulate miRNA biogenesis at the post-transcriptional level. 
 
TABLE 2. Long non-coding RNAs that regulate miRNA biogenesis at the post-
transcriptional level. 
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RBP miRNA biogenesis 
Step | effect 
Mechanism Target miRNAs Refs 
LIN28A 
Dicer | - Binds let-7 TL and 
blocks Dicer processing. 
Recruits TUTases (TUT4 
or TUT7) and induces 
oligouridylation. 
let-7, miR-9, miR-
107, miR-143, miR-
200c 
(Heo et al., 2009;  
Nowak et al., 2014)  
 
LIN28B 
Drosha | - Binds let-7 TL and 
blocks Drosha 
processing 
let-7 (Viswanathan et al., 
2008) 
hnRNP A1 
Drosha | + Promotes Drosha 
cleavage by 
restructuring pri-mir-18a 
miR-18a (Guil and Cáceres, 
2007; Michlewski et al., 
2008; Kooshapur et al., 
2018)  
 
Drosha | - Inhibits Drosha 
processing by competing 
out KSRP binding 
let-7 (Michlewski and 
Cáceres, 2010) 
KSRP 
Drosha and Dicer | + unknown let-7, miR-16, miR-
21, miR-26b, miR-
106a 
(Trabucchi et al., 2009, 
2010) 
TDP-43 
 
Drosha and Dicer | + unknown miR-132, miR-143, 
miR-558-3p, miR-
574-3p 
(Kawahara and Mieda-
Sato, 2012) 
SRSF1 Drosha | + unknown miR-7, miR-29b, miR-221, miR-222 
(Wu et al., 2010) 
FUS/TLS Drosha | + Recruits Drosha  co-transcriptionally 
miR-9, miR-125b, 
miR-132 
(Morlando et al., 2012) 
EWS Drosha | + Recruits Drosha  co-transcriptionally 
subset of miRNAs (Ouyang et al., 2017) 
RBFOX3 
Drosha | +  Binds to TL and 
facilitates 
Microprocessor 
recruitment 
miR-15 (Kim et al., 2014) 
Drosha | - Binds to the stem and 
blocks Microprocessor 
recruitment 
miR-485   
RBFOX2 
Drosha | - Binds to TL and leads to 
structural changes in the 
TL blocking 
Microprocessor binding 
and/or function 
miR-20b, miR-107 (Chen et al., 2016) 
HuR/MSI2 
Drosha | - HuR recruits MSI2, this 
complex stabilizes the 
stem and blocks 
Microprocessor cleavage 
miR-7 (Choudhury et al., 2013) 
ADAR1,2 
Drosha | - A to I editing in the stem 
leads to inhibition of 
Drosha cleavage 
miR-142 (Yang et al., 2006) 
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ADAR1 
Dicer |- A to I editing in the stem 
leads to inhibition of 
Dicer cleavage 
miR-151 (Kawahara et al., 2007) 
ADAR2 
Drosha | - Binds to stem and blocks 
Drosha processing 
independently of 
catalytic activity 
miR-376a (Heale et al., 2009) 
NF45/90 Drosha | - unknown miR-7 (Higuchi et al., 2016) 
YB-1 
Drosha | - 
Dicer |- 
unknown miR-29b-2 (Wu et al., 2015) 
MBNL1 
Dicer | + Binds to TL and 
competes out binding of 
the negative regulator 
LIN28 
miR-1 (Rau et al., 2011) 
BCDIN3D 
Dicer | - Methylates 
monophosphate ends  
of pre-miRNAs leading 
to inhibition of Dicer 
processing 
miR-145 (Xhemalce et al., 2012) 
SMADs 
Drosha | + Binds to p68 and 
promotes Drosha 
cleavage 
miR-21, miR-199a (Davis et al., 2008, 
2010) 
p53 
Drosha | +  Binds to p68 and 
promotes Drosha 
cleavage 
miR-16-1, miR-143, 
miR-145 
(Suzuki et al., 2009) 
BRCA1 Drosha | + unknown let-7a-1, miR-16-1, miR-145, miR-34a 
(Kawai and Amano, 
2012) 
 
TABLE 1. RNA-binding proteins that regulate miRNA biogenesis at the post-
transcriptional level. 
 
LIN28A/B, Protein lin-28 homolog A/B; hnRNP A1, heterogeneous nuclear ribonucleoprotein 
A1; KSRP, KH-type splicing regulatory protein; TDP-43, TAR DNA-binding protein 43; 
SRSF1,Serine and Arginine rich splicing factor 1; FUS/TLS, FUS RNA binding 
protein/Translocated in Liposarcoma; EWS, EWS RNA binding protein 1; RBFOX2,3, RNA 
binding protein fox-1 homolog 2/3; HuR, Hu Antigen R, also known as ELAV like RNA binding 
protein 1; MSI2, Musashi RNA binding protein 2; ADAR1,2, adenosine deaminase acting on 
RNA enzymes; NF45/90, Interleukin enhancer binding factor 2/3; YB-1, Y box binding protein 
1; ; MBNL1, Muscleblind-like protein 1; BDCIN3D, BCDIN3 Domain Containing RNA 
Methyltransferase; SMADs, Mothers against decapentaplegic homolog; p53, Tumor protein 
P53; BRCA1, Breast cancer type 1 susceptibility protein. 
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lncRNA miRNA biogenesis 
Step | effect 
Mechanism Target miRNAs Refs 
Uc.283+A 
Drosha | - Lower-stem strand 
invasion by Ic.283+A 
blocks Microprocessor 
recognition and efficient 
pri-miRNA processing 
miR-195 (Liz et al., 2014) 
RNCR4 
Drosha | + Stimulates the timed 
processing of this 
cluster. Antagonizes 
repression by the RNA 
helicase Ddx3x 
miR-183-96-182 
cluster 
(Krol et al., 2015) 
NEAT1 
Drosha | + NEAT1 interacts with the 
splicing factors NONO-
PSF and recruit the 
Microprocessor 
Global stimulation of 
miRNA production 
(Jiang et al., 2017) 
 
TABLE 2. Long non-coding RNAs that regulate miRNA biogenesis at the post-
transcriptional level. 
 
lncRNAs, long non- coding RNAs; Uc.283+A, transcribed ultraconserved region 283+A; 
RNCR4, retinal non- coding RNA 4; NEAT1, nuclear enriched abundant transcript 1. 
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